PUTRAJAYA, July 4 — The National Pharmaceutical Regulatory Division (NPRA) of the Ministry of Health (MOH) has cancelled the notification of four cosmetic products because...
KUALA LUMPUR, April 28 — The Health Ministry’s National Pharmaceutical Regulatory Agency (NPRA) has urged the public to refrain from buying and using three cosmetic...
PUTRAJAYA, April 13 — The assessment of the Covid-19 Vaccine Pharmacovigilance Special Committee (JFK) on 460 reports of adverse effects of immunisation (AEFI), found that...
KUALA LUMPUR, March 31 — The National Pharmaceutical Regulatory Division (NPRA) under the Ministry of Health (MOH) has advised the public against using two cosmetic...
KUALA LUMPUR, March 28 — All Covid-19 vaccine candidates that are being developed in the country have yet to be commercialised, the Dewan Negara was...
PUTRAJAYA, March 16 — Based on 451 reports on adverse events following immunisation (AEFI) that have been investigated and evaluated by the Covid-19 Vaccine Pharmacovigilance...